Director, Global Market Access and Pricing Strategy - Oncology

Job Title: Director, Global Market Access and Pricing Strategy - Oncology 

Location: Cambridge, MA or Morristown, NJ

About the Job

Join the team transforming care for people with immune challenges, rare diseases, cancers, and neurological conditions. In Specialty Care, you’ll help deliver breakthrough treatments that bring hope to patients with some of the highest unmet needs.

Sanofi Genzyme’s Oncology franchise has a diverse and fast-growing portfolio. This includes the late-stage launching assets (Sarclisa® / isatuximab / anti-CD38) in multiple myeloma, as well as earlier compounds in oncology. We are rapidly advancing a robust and reinvigorated oncology pipeline in different malignancies including colorectal and other GI cancers, lung cancers, and hematology.

Oncology is at the forefront of the key issues hence leadership in market access and pricing strategy as well as policy are critical for Sanofi success and support timely access. We are navigating in an uncertain and evolving environment, where different structural access hurdles have been identified/prioritized. Market Access is central to guiding cross-functional efforts to mitigate access-related risks and prepare for future pipeline launches.

 The primary purpose of the role is to support the development, update and execution of the Global Market Access and Pricing strategy, plans and tactics for the Oncology (hematology and solid tumor) pipeline through best-in-class methodologies under the guidance of the Oncology Global Market Access, Pricing and Policy Sr. Director for pipeline products. Main areas of focus will be as follows:

• Lead or support as per cases all relevant strategic and tactical activities to support Market Access inputs to the pipeline assets strategy (landscaping, payer requirements, value positioning, pricing/access assumptions, etc.)

• Lead or support as per cases across-brand projects as part of the Market Access, Pricing and Policy workforce, in collaboration with other functions (e.g., combinations challenges, alternative endpoints, etc.)

This is a highly collaborative role which will coordinate the relevant cross-functional projects and that must work cohesively with all relevant stakeholders within Market Access (HEVA, GMAX CoE, Affiliates…) and beyond (Commercial, Clinical, Medical, Regulatory, Biostatistics, etc.) to build successful access and pricing strategies, plan and tools in order to realize the full pricing and access potential of Sanofi solutions.

The role will report to the Oncology Global Market Access, Pricing & Policy Team Leader for pipeline products.

 The position will provide exposure to pre-POC, post-PoC and pre-launch activities.

About Sanofi:
We’re an R&D-driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth. Our deep understanding of the immune system – and innovative pipeline – enables us to invent medicines and vaccines that treat and protect millions of people around the world. Together, we chase the miracles of science to improve people’s lives.
 

Main Responsibilities:

• As per task / indication / asset, the incumbent will either support or lead the efforts according to needs, priorities and ramp-up. Increasing autonomy expected to grow over time.

• Collaborates with the development and supports execution of the access and pricing strategy in partnership with the therapeutic global cross-functional colleagues (e.g. Commercial, Clinical, medical, regulatory, etc.)

• Partners effectively with relevant departments (e.g. Commercial, Clinical Development, Regulatory Affairs, Medical Affairs, HEOR, etc.) to influence the market assessment, product positioning, and TPP by providing strategic input regarding market access, reimbursement and pricing information throughout the product life cycle.

For each indication / asset under scope, the incumbent will be responsible for the timely execution of assigned activities pertaining to the following areas (lead or support as per cases), such as:

• Foundational knowledge of disease and payer unmet need

• Competitive assessment

• Early market access success factors / risks identification

• Fact based early potential assessments (price/access assumptions for forecasting) and scenario development Informed market access input to development plan, evidence generation plan & pivotal trial design

• Coordinates the relevant Market Access cross-functional working groups / sub-team / projects ensuring relevant input / engagement from key markets

• Develops and maintains a high level of knowledge with regards to the scientific, clinical,